Michael Donahue Decker, MD
NPI 1710212840ActiveIndividual· Internal Medicine, Infectious Disease· Baxter, TN
Internal Medicine, Infectious Disease (MD) in Baxter, Tennessee, licensed in TN, with an NPI issued in October 2009. Part D covered 17 prescriptions written in 2024, 100% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $4,028 in all, mostly consulting fees.
Overview
| NPI | 1710212840 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Oct 7, 2009 |
| Last updated in NPPES | Apr 9, 2017 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Infectious Disease Primary | 207RI0200X | MD0000014250 | TN |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 17 · 27 30-day fills |
|---|---|
| Total drug cost | $198.61 |
| Generic share | 100% of claims |
Industry payments (Open Payments)
- 2025$4,028 · 2 payments from 2 companies
- 2024$6,686 · 4 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,071 | 1 |
| Valneva USA, Inc. | $956.67 | 1 |
What the 2025 payments were for
- Consulting Fee$4,028 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records